Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GLG Partners is an alternative investment management firm best known for discretionary hedge fund and long-only investment strategies across equities, credit, and multi-asset classes. It was founded in 1995 and later became part of Man Group, which acquired GLG in 2010. Today the business is generally referred to as Man GLG and operates as a discretionary investment manager within Man Group rather than as a life sciences or biopharma company. Although the broader GLG brand can appear in healthcare-related contexts, the entity named "GLG Partners" refers to the investment manager, not a biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GLG Partners.